28 studies found for:    " December 24, 2008":" January 23, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)
Conditions: HIV/AIDS;   HIV Infections
Intervention: Drug: ETHINYL ESTRADIOL AND LEVOGESTREL
22 Terminated Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
Conditions: HIV Infections;   Helminthiasis
Intervention: Drug: Praziquantel, Ivermectin, Albendazole
23 Terminated
Has Results
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
Condition: HIV-1
Interventions: Drug: UK-453,061 Dose 1;   Drug: UK-453,061 Dose 2;   Drug: Etravirine
24 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
25 Completed
Has Results
Chloroquine for Reducing Immune Activation in HIV- Infected Individuals
Condition: HIV Infections
Interventions: Drug: Chloroquine;   Drug: Placebo
26 Completed Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults
Condition: HIV Infections
Intervention: Drug: Structured treatment interruption
27 Completed Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629
Condition: HIV-I
Intervention: Drug: TMC114; TMC41629
28 Recruiting S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
Conditions: Lymphoma;   Nonneoplastic Condition
Interventions: Biological: bleomycin sulfate;   Biological: filgrastim;   Drug: ABVD regimen;   Drug: BEACOPP regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: prednisone;   Drug: procarbazine hydrochloride;   Drug: vinblastine sulfate;   Drug: vincristine sulfate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-28) Next Page   
Indicates status has not been verified in more than two years